Lectin Microarray Assay
CD BioGlyco has rich experience in lectin microarray assay. Our multiple technology platforms and well-trained researchers can provide customers with various forms of sample testing. We have confidence to be your essential research assistant in the field of glycobiology.
Background
Lectin is a glycoprotein that can bind to sugar, be synthesized secreted by animal cells and plant cells. Lectins can recognize complex carbohydrate structures in glycoproteins and glycolipids, as well as sugar groups on the surface of cell membranes. Therefore, lectin is a useful tool for studying cell membrane structures, cell recognition and adhesion reactions. In addition, because of its multivalent binding ability, lectin can bind to luciferin, enzymes, ferritin, biotin, etc. without affecting its biological activity. Therefore, lectin can also be used in immunocytochemistry research and tumor diagnosis. Start a new paragraph: Lectin microarray is a new method of glycan profile analysis based on lectin. It has become a very promising method in the field of glycomics and glycoproteomics. It uses a set of lectins fixed on a solid surface to perform rapid analysis of glycoprotein glycosylation profile and glycoform characterization, and can be directly applied to both pure and crude form (for example, clinical samples) of glycoprotein. Unlike other conventional methods (such as liquid chromatography and mass spectrometry), it can analyze complex glycan characteristics quickly and with high sensitivity without releasing glycans. Although this technique is not quantitative, it's more efficiently applied for comparative purposes, such as differential profiling.
Fig. 1 Lectin and antibody microarrays are used for glycan analysis and bacterial detection. (Campanero-Rhodes, et al., 2020)
Services
CD BioGlyco uses the following methods to perform lectin microarray assay.
We provide professional lectin microarray system, including equipment, microarray plate and various detection technologies (Confocal fluorescence detection method/ Evanescent-field activated fluorescence detection method/ Bimolecular fluorescence quenching and recovery method). Subsequently, we develop a set of advanced and general procedure to prepare samples which can be used for various forms of samples such as serum, urine, cell lysates and tissue extracts. Professional technicians will perform fluorescent labeling and data analysis and finally draw a precise conclusion.
Our microarrays contain multiple lectins for glycan analysis. All lectins have been validated to ensure their binding specificity. By fluorescently labeling samples, incubating them with the microarray, and quantitatively detecting fluorescent interactions, we analyze the glycome of the samples. We deliver histograms, data files, and detailed result discussions. Additionally, lectin microarrays can be customized to meet various personalized needs and tested and analyzed according to specific requirements. Whether your research objectives involve disease biomarker discovery, drug development, or fundamental glycobiology exploration, our lectin chip services provide robust data support.

Workflow
Our lectin microarray service follows strict quality control standards to ensure data accuracy and reliability, including the following:
- Sample reception: We receive the samples and perform the necessary sample preparation and protein separation steps. We then label the samples with fluorescent dyes and clean them.
- Lectin microarray incubation: The processed samples are incubated with our pre-prepared high-quality lectin chips, and conditions are optimized to ensure that target molecules bind to the corresponding lectins.
- Binding analysis: Fluorescent signals are scanned using a high-resolution microarray scanner, and image data is quantitatively analyzed using specialized software.
- Data processing: We standardize the raw data and perform lectin interaction analysis, and complete a detailed detection report. The binding data is provided in the form of a histogram. The report also includes the raw data and fluorescent images of the lectin microarray after incubation.
Applications
- Glycan-related biomarker research: By analyzing the glycosylation characteristics of inflammatory diseases, neurodegenerative diseases, tumors, etc., to promote the discovery of disease-related biomarkers.
- Drug development: Utilizing lectin microarrays for glycosylation analysis of biopharmaceuticals can provide data support for analyzing the impact of glycosylation on drug efficacy, safety, and immunogenicity, as well as evaluating drug production processes.
- Glycoprotein analysis under functional glycomics: Analysis using lectin microarrays helps understand the role of glycoproteins in cell-to-cell communication, adhesion, migration, signaling pathways, etc.
Advantages
- Our lectin microarray is well-suited for the simultaneous analysis of multiple samples, providing rapid results in a simple and user-friendly format.
- Our lectin microarray is suitable for the analysis of various biological samples, such as proteins, antibodies, cells, cell lysates, serum, bacteria, etc.
- The assay has high sensitivity and specificity and is suitable for detecting minute glycosylation changes in low-abundance glycoproteins.
Publication Data
Technology: Lectin microarray
Journal: Scientific Reports
IF: 4.122
Published: 2017
Results: This study established a lectin-assisted tissue glycometry analysis method. Researchers prepared tissue sections from the mouse brain, liver, kidney, spleen, and testis, and continuously collected multiple fragments using laser microdissection technology, followed by lectin microarray analysis. Analysis and validation revealed that this method can generate semi-quantitative data, providing insights into the distribution, dominance, and characteristics of glycan epitopes in different tissue sections. It is simple to operate and suitable for ultra-sensitive, reproducible, and high-throughput analysis. Additionally, this method applies to studies of various disease model mice and the discovery of disease-related biomarkers.
Fig. 2 Differential glycomics analysis of tissue fragments. (Zou, et al., 2017)
Frequently Asked Questions
CD BioGlyco has provided reliable and cost-effective research services to customers all over the world, and our considerate service and professional technology in the field of glycobiology have won us a great deal of praise.
Customers can contact our employees directly and we will respond promptly. If you are interested in our services, please contact us for more detailed information.
Associated Services

- Conjugation Strategy for Glycan Linking to Coat Protein pVIII
- Engineered M13 Bacteriophage Construction Service
- O-Xyl Pathway-based Glyco-engineered Cell Construction Service
- O-Gal Pathway-based Glyco-engineered Cell Construction Service
- O-GlcNAc Pathway-based Glyco-engineered Cell Construction Service
- Glycan Elongation/branching Pathway-based Glyco-engineered Cell Construction Service
- Glycan Capping Pathway-based Glyco-engineered Cell Construction Service
References
- Campanero-Rhodes, M.A.; et al. Microarray strategies for exploring bacterial surface glycans and their interactions with glycan-binding proteins. Frontiers in Microbiology. 2020, 10: 2909. (Open Access)
- Zou, X.; et al. A standardized method for lectin microarray-based tissue glycome mapping. Scientific reports. 2017, 7(1): 43560. (Open Access)
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





